Year
2026
-
Reinsurance Group of America Announces Fourth Quarter Earnings Release Date, Webcast
-
Devon Bray Joins Hancock Whitney as Business Banking & SBA Director
-
Valley National Bancorp to Announce Fourth Quarter 2025 Earnings
-
SonoThera Launches $125M Series B at 44th J.P. Morgan Healthcare Conference to Advance Multiple Genetic Medicine Programs Toward First-in-Human Studies
-
ALX Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Duke Energy Foundation launches America250 grant opportunity for nonprofits in six states
-
XA Investments Launches INTVL-C, an Extension to Its Interval Fund Index Suite Focused on Alternative Credit Interval & Tender Offer Funds
-
W. R. Berkley Corporation Increases Share Repurchase Authorization
-
State Street Supports Columbia Threadneedle UCITS ETF Launch
-
Duke Energy to announce fourth-quarter and year-end 2025 financial results on Feb. 10
-
National Advertising Division Finds Certain T-Mobile Claims Supported, Recommends Modifications to Others; T-Mobile to Appeal
-
Exelon Names Tim Peterson Chief Customer and Technology Officer
-
NDEX Systems Announces New Integrated Single Sign-On and Streamlined Client Onboarding Experience with Schwab Advisor Center®
-
Zifo at JPM Healthcare Conference 2026: Why Technology Alone Cannot Deliver the AI Promise
-
Encoded Therapeutics Highlights Progress in Dravet Syndrome Program and Pipeline Ahead of Company Presentation at 44th Annual J.P. Morgan Healthcare Conference
-
AI Investment Accounted for Nearly Half of Healthcare Investment in 2025; Silicon Valley Bank Releases 17th Healthcare Investments and Exits Report
-
Diana Shipping Inc. Announces Direct Continuation of Time Charter Contract for m/v Maia with Paralos Shipping
-
Majority of Gen X Feels Confident in Their Investment Decisions, Yet 40% Lack a Formal Financial Plan
-
UMB Announces Conference Call to Discuss Fourth Quarter 2025 Results
-
Bounty Returns as the Ultimate Wingman – Tackling Gameday Messes from Playoffs to Super Bowl LX
-
Lumen Technologies, Inc. Announces Expiration and Results of Previously Announced Tender Offers and Consent Solicitations
-
Immorta Bio Doubles Mouse Lifespan Using Combination Senolytic and Regenerative Therapy in Validated Aging Models
-
NewtekOne, Inc. Posts Investor Day Presentation and Provides 2026 EPS Guidance Range of $2.15-$2.55
-
TPG to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Investor Call
-
32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics